arrow-right cart chevron-down chevron-left chevron-right chevron-up close menu minus play plus search share user email pinterest facebook instagram snapchat tumblr twitter vimeo youtube subscribe dogecoin dwolla forbrugsforeningen litecoin amazon_payments american_express bitcoin cirrus discover fancy interac jcb master paypal stripe visa diners_club dankort maestro trash
Genestra HMF Intensive 50 30 Veggie Caps
Regular price
$94.89

Genestra HMF Intensive 50 30 Veggie Caps

Genestra

Unit price per

HMF INTENSIVE 50

  • Allergen Free Formula
  • Vegan
  • Free From Gluten
  • Free From GMO
  • Free From FOS
  • Free From Starch
  • Free From Yeast
  • Free From Corn
  • Free From Soy
  • Free From Sodium
  • Free From Sugar
  • Free From Artificial Colouring Or Flavouring
  • Free From Dairy Or Animal Products

Delayed-release, shelf-stable probiotic formula

  • Supports gastrointestinal health
  • Provides 50 billion CFU per dose from a combination of four proprietary strains
  • Formulated with acid-resistant and delayed-release capsules for targeted delivery to the intestines
  • Convenient, once-daily capsule format

HMF Intensive 50 is a shelf-stable probiotic formula that offers 50 billion CFU from a combination of four proprietary strains. These microorganisms have been used in a wide body of clinical research and are one of the most studied probiotic combinations worldwide.1-6 Research has demonstrated that these strains support a healthy gut flora and promote gastrointestinal comfort.1-4 In addition, these human-sourced strains were selected based on their high quality and viability, strong epithelial adherence, and naturally high tolerance to stomach and bile acid.7 To further enhance probiotic survivability through the stomach, HMF Intensive 50 is produced with delayed release capsules. Each capsule is formulated with unique polymer properties that resist stomach acid and delay the release of probiotics after swallowing, allowing for complete, targeted release in the intestines and optimal probiotic activity.8

References
1. Madden, JA, Plummer, SF, Tang, J, Garaiova, I, Plummer, NT, Herbison, M, Hunter, JO, Shimada, T, Cheng, L, Shirakawa, T. Int Immunopharmacol. 2005; 5(6): 1091-1097.
2. Plummer, SF, Garaiova, I, Sarvotham, T, Cottrell, SL, Le Scouiller, S, Weaver, MA, Tang, J, Dee, P, Hunter, J. Int J Antimicrob Agents. 2005; 26(1): 69-74.
3. Plummer, S, Weaver, MA, Harris, JC, Dee, P, Hunter, J. Int Microbiol. 2004; 7(1): 59-62.
4. Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. Aliment Pharmacol Ther. 2009; 29(1): 97-103.
5. Garaiova, I, Muchová, J, Nagyová, Z, Wang, D, Li, JV, Országhová, Z, Michael, DR, Plummer, SF, Ďuračková, Z. Eur J Clin Nutr. 2015; 69(3): 373-379.
6. Allen, SJ, Jordan, S, Storey, M, Thornton, CA, Gravenor, M, Garaiova, I, Plummer, SF, Wang, D, Morgan, G. J Nutr. 2010; 140(3): 483-488.
7. Seroyal. Data on file.
8. Amo, R. Capsugel®. (2014). DRcaps® Capsules Achieve Delayed Release Properties for Nutritional Ingredients in Human Clinical Study. [White Paper].


Shopping Cart